JHS Svendgaard to vary use of Rs 30 crore preferential issue proceeds
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JHS Svendgaard Labs board approved varying the use of proceeds from its preferential issue worth about Rs 30 crore. Earlier earmarked for equipment purchase and group entity funding, the funds will now be used for broader capital expenditure, business expansion, strategic investments and acquisitions. General corporate purpose allocation stays at Rs 7.5 crore. Deployment timeline extended to March 31, 2027. Change described as clarificatory but broadens fund usage. Subject to shareholder approval.
Broader flexibility in fund use may support growth plans, but raises questions on original promises. Watch shareholder approval and deployment.